T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Clinical trials for T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested to keep aggressive blood cancers at bay after transplant
Disease control CompletedThis study tested whether adding a low-dose drug called chidamide after a stem cell transplant could help prevent cancer from returning in patients with T-cell leukemia or lymphoma. It involved 44 patients who had already received a transplant and were in remission but at high ri…
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo tested in High-Stakes fight against rare blood cancers
Disease control CompletedThis study tested whether adding the drug romidepsin to a stem cell transplant could better control several aggressive types of T-cell blood cancers. Researchers gave romidepsin before and after the transplant to 23 patients to find the safest dose and see if it helped. The main …
Matched conditions: T LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC